Marine Bioactive Compounds against Aspergillus fumigatus: Challenges and Future Prospects

Area of Science:

• Marine biology
• Medicinal chemistry
• Mycology

Background:

• Invasive aspergillosis, caused by Aspergillus fumigatus, has a high mortality rate, especially in immunocompromised patients.
• Increasing resistance of Aspergillus fumigatus to current antifungal drugs necessitates the urgent development of new therapeutic agents.
• Marine environments are a rich source of diverse bioactive compounds with potential pharmaceutical applications.

Purpose of the Study:

• To review marine bioactive compounds with demonstrated antifungal activity against Aspergillus fumigatus.
• To analyze the challenges hindering the discovery of effective antifungal agents from marine sources.
• To propose strategies for accelerating the discovery and broadening the scope of screening for novel marine-derived antifungals.

Main Methods:

• Literature review of scientific publications on marine bioactive compounds and their antifungal properties.
• Analysis of reported bioactivities against Aspergillus fumigatus.
• Critical evaluation of challenges in marine natural product drug discovery.
• Synthesis of proposed strategies for future research and development.

Main Results:

• A limited number of marine bioactive compounds have shown significant antifungal activity against Aspergillus fumigatus compared to other pathogens.
• Key challenges include compound isolation, characterization, low yields, and difficulties in demonstrating in vivo efficacy.
• Despite challenges, marine natural products represent a promising, yet underexplored, resource for novel antifungal drug leads.

Conclusions:

• Marine bioactive compounds hold potential for developing new treatments against invasive aspergillosis.
• Overcoming discovery and development hurdles is crucial for harnessing marine resources effectively.
• Innovative screening strategies and further research are needed to identify potent, in vivo active antifungal agents from the sea.